CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net income/(loss)	$ (3,411)	$ 5,637
Depreciation and tooling amortization	5,669	5,478
Other amortization	(876)	(1,034)
(Gains)/Losses on extinguishment of debt (Note 4 and Note 15)	121	8
Held for sale impairment charges	32	0
Provision for/(Benefit from) credit losses and insurance losses	(70)	(250)
Pension and other post-retirement employee benefits (“OPEB”) expense/(income) (Note 14)	(595)	(1,115)
Equity method investment dividends received in excess of (earnings)/losses and impairments (Note 10)	2,975	95
Foreign currency adjustments	(71)	348
Net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments	7,365	(899)
Net (gain)/loss on changes in investments in affiliates (Note 4)	137	(354)
Stock compensation	277	262
Provision for/(Benefit from) deferred income taxes	(1,557)	652
Decrease/(Increase) in finance receivables (wholesale and other)	(6,601)	8,508
Decrease/(Increase) in accounts receivable and other assets	(2,370)	(1,329)
Decrease/(Increase) in inventory	(4,160)	(3,129)
Increase/(Decrease) in accounts payable and accrued and other liabilities	8,453	(511)
Other	357	(111)
Net cash provided by/(used in) operating activities	5,675	12,256
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]
Capital spending	(4,801)	(4,455)
Acquisitions of finance receivables and operating leases	(32,988)	(34,693)
Collections of finance receivables and operating leases	35,676	39,440
Proceeds from sale of business (Note 18)	435	145
Purchases of marketable securities and other investments	(14,115)	(23,243)
Sales and maturities of marketable securities and other investments	16,208	28,439
Settlements of derivatives	233	(244)
Other	(23)	(381)
Net cash provided by/(used in) investing activities	625	5,008
Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]
Cash payments for dividends and dividend equivalents	(1,410)	(3)
Purchases of common stock	0	0
Net changes in short-term debt	1,650	1,568
Proceeds from issuance of long-term debt	32,855	19,300
Payments of long-term debt	(37,395)	(36,122)
Other	(244)	(163)
Net cash provided by/(used in) financing activities	(4,544)	(15,420)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract]
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(772)	(155)
Net increase/(decrease) in cash, cash equivalents, and restricted cash	984	1,689
Cash, cash equivalents, and restricted cash at beginning of period (Note 7)	20,737	25,935
Cash, cash equivalents, and restricted cash at end of period (Note 7)	$ 21,721	$ 27,624